John Overdeck’s Astrana Health ASTH Stock Holding History

John Overdeck’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,713	Closed	-$762K	–	4976
2025 Q4	$762K	Buy	+30,713	New	+$816K	﹤0.01%	3092
2025 Q1	–	Sell	-14,793	Closed	-$466K	–	3536
2024 Q4	$466K	Buy	+14,793	New	+$703K	﹤0.01%	2570
2024 Q1	–	Sell	-11,100	Closed	-$425K	–	3432
2023 Q4	$425K	Hold	11,100	–	–	﹤0.01%	2543
2023 Q3	$342K	Hold	11,100	–	–	﹤0.01%	2439
2023 Q2	$351K	Hold	11,100	–	–	﹤0.01%	2472
2023 Q1	$405K	Buy	11,100 +3,800	+52%	+$133K	﹤0.01%	2297
2022 Q4	$216K	Buy	+7,300	New	+$235K	﹤0.01%	2367
2022 Q2	–	Sell	-32,943	Closed	-$1.6M	–	3006
2022 Q1	$1.6M	Buy	+32,943	New	+$1.7M	﹤0.01%	1461
2021 Q2	–	Sell	-51,598	Closed	-$1.4M	–	4659
2021 Q1	$1.4M	Sell	51,598 -5,769	-10%	-$139K	﹤0.01%	2011
2020 Q4	$1.05M	Sell	57,367 -61,435	-52%	-$1.1M	﹤0.01%	1974
2020 Q3	$2.13M	Buy	+118,802	New	+$2.05M	0.01%	1259

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

John Overdeck's ASTH Position: Q1 2026 in Review

John Overdeck sold out of Astrana Health (ASTH) in Q1 2026, closing a stake of 30,713 shares — an estimated $762K sold.

John Overdeck first reported a position in ASTH in Q3 2020 and held it in 11 quarters. The position peaked at $2.13M in Q3 2020. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

John Overdeck reported no remaining Astrana Health position as of Q1 2026 after selling out during the quarter.
John Overdeck sold 30,713 Astrana Health shares in Q1 2026, an estimated $762K.
John Overdeck first reported a position in Astrana Health in Q3 2020 and held it in 11 quarters.
John Overdeck's Astrana Health position peaked at $2.13M in Q3 2020.
171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.